Cite
HARVARD Citation
Piñeyroa, J. et al. (2022). Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia. Hematological oncology. 40 (4), pp. 588-595. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Piñeyroa, J. et al. (2022). Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia. Hematological oncology. 40 (4), pp. 588-595. [Online].